Skip to main content
20 minutes minimum delay
toggle main navigation
Our Approach
Our Approach
NDMA Receptors
Therapeutic Area Focus
Pipeline
Clinical Studies
Investors
About Us
About Aptinyx
Leadership Team
Board of Directors
Working at Aptinyx
Contact Us
Site Search
Press Releases
Investor Relations
Press Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials & Filings
Quarterly Results
Annual Reports & Proxy
SEC Filings
Governance
Governance Documents & Charters
Executive Management
Board of Directors
Committee Composition
FAQ & Contacts
Investor Contacts
Investor FAQs
Investor Email Alerts
RSS Feeds
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
December 20, 2021
Aptinyx to Host Virtual Portfolio Review Event on February 9th, 2022
Download
PDF format download (opens in new window)
December 16, 2021
Aptinyx Initiates Phase 2b Study of NYX-783 in Patients with Post-Traumatic Stress Disorder
Download
PDF format download (opens in new window)
December 13, 2021
Aptinyx to Present at the 40th Annual J.P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)
November 18, 2021
Aptinyx to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
Download
PDF format download (opens in new window)
November 09, 2021
Aptinyx Reports Third Quarter 2021 Financial Results and Recent Highlights
Download
PDF format download (opens in new window)
October 27, 2021
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
Download
PDF format download (opens in new window)
October 25, 2021
Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
Download
PDF format download (opens in new window)
October 20, 2021
Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors
Download
PDF format download (opens in new window)
September 20, 2021
Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference
Download
PDF format download (opens in new window)
September 16, 2021
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
Download
PDF format download (opens in new window)
August 31, 2021
Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Download
PDF format download (opens in new window)
August 10, 2021
Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
Download
PDF format download (opens in new window)
August 03, 2021
Aptinyx to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
Download
PDF format download (opens in new window)
July 26, 2021
Aptinyx to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
Download
PDF format download (opens in new window)
July 12, 2021
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
Download
PDF format download (opens in new window)
July 06, 2021
Aptinyx to Participate in Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
Download
PDF format download (opens in new window)
June 17, 2021
Aptinyx to Participate in Upcoming Investor Conferences
Download
PDF format download (opens in new window)
June 15, 2021
Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder
Download
PDF format download (opens in new window)
May 13, 2021
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
Download
PDF format download (opens in new window)
May 10, 2021
Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors
Download
PDF format download (opens in new window)
April 29, 2021
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
Download
PDF format download (opens in new window)
April 29, 2021
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting
Download
PDF format download (opens in new window)
April 27, 2021
Aptinyx to Participate in Upcoming Conferences
Download
PDF format download (opens in new window)
April 06, 2021
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
Download
PDF format download (opens in new window)
March 24, 2021
Aptinyx Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
March 02, 2021
Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021
Download
PDF format download (opens in new window)
February 22, 2021
Aptinyx to Participate in Upcoming Investor Conferences
Download
PDF format download (opens in new window)
February 11, 2021
Aptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference
Download
PDF format download (opens in new window)
January 19, 2021
Aptinyx Announces Publication of Review Article Highlighting Preclinical Data in Medicine in Drug Discovery Demonstrating the Potential of NYX-2925 to Treat Chronic, Centralized Pain Conditions
Download
PDF format download (opens in new window)
January 05, 2021
Aptinyx to Participate in H.C. Wainwright BioConnect 2021 Conference
Download
PDF format download (opens in new window)
January 04, 2021
Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy
Download
PDF format download (opens in new window)